Chemical and Pharmaceutical Bulletin p. 184 - 193 (2000)
Update date:2022-09-26
Topics:
Okada, Yoshio
Matsumoto, Yoshikazu
Tsuda, Yuko
Tada, Mayako
Wanaka, Keiko
Hijikata-Okunomiya, Akiko
Okamoto, Shosuke
Various compounds were synthesized by combining three components at positions P1, P1, and P2,. Of these, N-(trans-4- aminomethylcyclohexanecarbonyl)-Tyr(O-2-bromobenzyloxycarbonyl)-octylamide inhibited plasmin selectively with IC50 values of 0.80 and 0.23 μM towards S-2251 and fibrin, respectively. This compound also inhibited plasma kallikrein, urokinase, thrombin and trypsin with IC50 values of 10, >50, >50 and 1.6 μM, respectively.
View MoreJiangsu Zenji Pharmaceuticals LTD
Contact:+86-025-83172562; +1-224-888-1133(USA)
Address:No.5 Xinmofan Road
ShanDong XinDa Chemical CO.,LTD(expird)
Contact:086-0311-87580543
Address:No.168, High Technology Development Zone Jinan Shandong China
website:http://www.acrospharmatech.com
Contact:+1-3234804688
Address:Flat/RM 1502,Easey Commercial building 253-261 Hennessy Road,Wanchai,HongKong
Yixing Bluwat Chemicals Co., Ltd.
Contact:+86 510 87821568
Address:Yongan Road, Yixing Chemical Industrial Park, Yixing, Jiangsu, China
Taizhou Chenyi chemical co. LTD,
Contact:13736652831
Address:NO.273 SHANGHAI SOUTH STREET,LUQIAO DISTRICT,ZHEJIANG PROVINCE,CHINA.
Doi:10.1021/ja01349a029
(1932)Doi:10.1080/00397910008087117
(2000)Doi:10.1021/jo00803a026
(1971)Doi:10.1016/j.tetasy.2016.11.007
(2017)Doi:10.1016/j.poly.2012.06.079
(2013)Doi:10.1021/om400130m
(2013)